Timothy Sullivan Overview
- Investor Type
-
Angel
- Investments
-
2
- Exits
-
2
Timothy Sullivan General Information
Description
Mr. Timothy Sullivan serves as Chief Financial Officer at Apellis. He serves as a Board Member at Allysta. He has served as our chief financial officer since October 2017. From January 2014 to October 2017, he served as a Partner at Aju IB Investment, a venture capital firm, at which he led the firm's investments in life sciences companies. Before joining Aju IB Investment, from December 2011 to January 2014, he was Managing Director and Head of life sciences investment banking at RBS Citizens. He was an observer on the board of directors from November 2014 until October 2017. He has previously served as a director of G1 Therapeutics and Molecular Templates. He received his MBA degree from the Columbia Business School and his BA degree in biology from Harvard University.
Business Details
Primary Investor Type
Timothy Sullivan Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Syncurity | 01-Dec-2018 | Seed Round | Other Commercial Services | Generating Revenue | ||
Atea Pharmaceuticals | 17-Sep-2014 | Drug Discovery | Clinical Trials - Phase 2 |
Timothy Sullivan Exits (2)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Atea Pharmaceuticals | 30-Oct-2020 | IPO | |
Syncurity | 16-Apr-2020 |
Timothy Sullivan Investments by Industry, Year, and Region
Timothy Sullivan FAQs
-
Who is Timothy Sullivan?
Timothy Sullivan is an angel Investor who has made 2 investments.
-
What kind of investor is Timothy Sullivan?
Timothy Sullivan is an angel investor.
-
What does Timothy Sullivan do?
As an angel investor, Timothy Sullivan invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Timothy Sullivan hold?
Timothy Sullivan holds a board seat in Allysta.
-
What has Timothy Sullivan invested in?
Timothy Sullivan has made numerous investments in companies like Syncurity and Atea Pharmaceuticals within the Commercial Services and Drug Discovery industries.
-
What has Timothy Sullivan invested in recently?
Timothy Sullivan's latest investment was on 01-Dec-2018 in Syncurity, a company within the Commercial Services industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »